Incidence and prevalence of multidrug-resistant acinetobacter using targeted active surveillance cultures

JAMA

Volumn 299, Issue 21, 2008, Pages 2513-2514

  Maragakis, Lisa L ^a   Tucker, Margaret G ^a   Miller, Redonda G ^a   Carroll, Karen C ^a   Perl, Trish M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; COHORT ANALYSIS; GRAM NEGATIVE BACTERIUM; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE UNIT; LAW; LETTER; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 44649173118     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.299.21.2513     Document Type: Letter

References (6)

1. MRSA Screening and Reporting Act: Illinois Public Act 095-0312. Illinois General Assembly. http://www.ilga.gov/legislation/publicacts/95/095-0312.htm. Accessed April 10, 2008.
2. Richet H, Fournier PE. Nosocomial infections caused by Acinetobacter baumannii: a major threat worldwide. Infect Control Hosp Epidemiol. 2006;27(7):645-646.
3. Diekema DJ, Edmond MB. Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis. 2007;44(8):1101-1107.
4. Sunenshine RH, Wright MO, Maragakis LL, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis. 2007;13(1):97-103.
5. Kwon KT, Oh WS, Song JH, et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother. 2007;59(3):525-530.
6. Marchaim D, Navon-Venezia S, Schwartz D, et al. Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol. 2007;45(5):1551-1555.